ArticleBMC cardiovascular disorders2025
A machine-learning-derived online screening tool for depressive symptoms in patients with cardiovascular and cerebrovascular diseases (CCVD): a cross-sectional study with temporal validation from CHARLS.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveDepressive symptoms are significant and deleterious complication of cardiovascular and cerebrovascular diseases (CCVD), profoundly impairing patients’ quality of life. This study aimed to develop and validate an online screening model to estimate the risk of depressive symptoms among patients with CCVD.
methodsThis study utilized data from the 2020 China Health and Retirement Longitudinal Study (CHARLS), including 4,086 patients with CCVD. A total of 31 behavioral, health-related, psychological, and sociodemographic indicators were evaluated. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression, Random Forest (RF), and the Boruta algorithm. Six machine learning models, Logistic Regression (LR), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), Decision Tree, RF, and XGBoost, were developed and compared. The best-performing model was used to construct a clinically interpretable nomogram, which was deployed as a real-time, web-based risk screening tool via a Shiny application. Temporal validation was conducted using CHARLS 2015 data.
resultsAmong the 4,086 CCVD patients included, 1,990 (48.70%) exhibited depressive symptoms. Feature selection identified 13 key variables. The Logistic Regression model demonstrated superior performance among the tested algorithms, with an AUC of 0.767, and showed moderate discriminative ability (C-index = 0.776, 95% CI: 0.761–0.790) and good calibration (Hosmer–Lemeshow test, P = 0.51). The model was implemented into a freely accessible online calculator for real-time risk assessment.
conclusionUsing machine learning approaches, this study developed and validated a screening model with moderate discriminative ability for estimating the risk of depressive symptoms in CCVD patients. The online Shiny-based calculator serves as a practical screening tool for clinicians, supporting early identification and intervention in high-risk populations. Further prospective validation is warranted to assess its real-world utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.